Pharmaceutical Partnerships

Business

Hong Kong Set to Issue First Stablecoin Licenses in March, Regulator Confirms Limited Initial Approvals

The Hong Kong Monetary Authority (HKMA) is poised to grant its inaugural stablecoin issuer licenses in March, with approvals expected for only a select few firms. The move transitions the city's digital asset framework from sandbox testing to a formally regulated market, focusing on stringent risk controls and credible use cases.

Feb 2, 2026

Business

Bitcoin ETF Investors Face Losses as Heavy Withdrawals Push Prices Below Average Purchase Cost

Recent data shows the average Bitcoin held by U.S. spot ETFs is now worth less than its purchase price, following two consecutive weeks of major outflows that have deepened the cryptocurrency's downturn.

Feb 2, 2026

Business

Alphabet's AI Momentum and Cloud Surge Fuel Optimism Ahead of Q4 Earnings

With its core search business resilient, cloud division soaring, and new AI deals like the Apple partnership taking shape, Alphabet enters its February 4 earnings report on a strong note, though regulatory and valuation concerns linger.

Feb 2, 2026

Business

Harmony CFO's Complete Stock Sale Raises Eyebrows Amid Upbeat Revenue Forecasts

Harmony Biosciences CFO Sandip Kapadia has liquidated his entire direct stake in the company, a move that contrasts sharply with the firm's robust financial performance and bullish $1 billion revenue target for its flagship drug WAKIX by 2026. While the sales were pre-planned, the timing fuels debate on insider confidence versus corporate optimism.

Feb 2, 2026

Business

FDA Expands Glaukos' iDose TR Implant Approval, Paving Way for Repeat Use in Glaucoma Management

Glaukos Corporation secures a significant FDA nod allowing repeated administration of its sustained-release iDose TR implant, broadening treatment options for patients with glaucoma and potentially reshaping long-term care paradigms.

Feb 2, 2026

Business

Quantum Leap South: D-Wave Relocates HQ from Silicon Valley to Florida, Fueling Tech Exodus Debate

D-Wave Quantum Inc. announces the relocation of its headquarters and core R&D from Palo Alto, California, to Boca Raton, Florida, citing the state's business climate and partnership opportunities, in a move emblematic of a wider coastal tech migration.

Feb 2, 2026

Business

iRhythm Completes Corporate Overhaul, Establishes New Holding Company Structure

Cardiac monitoring specialist iRhythm has finalized a significant corporate restructuring, creating a new parent company to serve as its publicly listed entity on Nasdaq. The move is seen as a strategic step to streamline governance and provide operational flexibility as the company expands its AI-driven health platform.

Feb 2, 2026

Business

Travere Therapeutics Under Investigation: Legal Scrutiny Clouds Biotech's Path to Profitability

Travere Therapeutics faces a securities fraud investigation by Robbins Geller Rudman & Dowd LLP, raising questions about the accuracy of its past disclosures. The probe casts a shadow over the company's critical transition, as it banks on its kidney drug FILSPARI to drive growth amid mounting legal and commercial pressures.

Feb 2, 2026

Sanofi's Genetic Disorder Drug Shows Promise in Gaucher Trial, Stumbles in Fabry Study

Sanofi's experimental oral drug venglustat demonstrated significant neurological benefits for patients with Type 3 Gaucher disease in a late-stage trial, but failed to meet its primary endpoint in a separate study for Fabry disease, casting uncertainty on its regulatory path.

Feb 2, 2026

Business

Abu Dhabi's Ruya Partners Seeks $400 Million for Major Gulf Private Credit Fund

Backed by regional sovereign wealth giants, Ruya Partners is launching a $400 million fund to address middle-market lending gaps in Saudi Arabia and the UAE, positioning itself as a key player in the Gulf's burgeoning private credit landscape.

Feb 2, 2026

Business

Beneath the Radar: Three Asian Small-Caps Under $200M Drawing Investor Scrutiny

Amidst shifting economic currents in Asia, a class of smaller companies—often overlooked as 'penny stocks'—is attracting attention for their distinct financial profiles and niche market positions. We analyze three such firms with market capitalizations below US$200 million.

Feb 2, 2026

Business

Beyond the Headlines: Three Middle Eastern Penny Stocks Drawing Investor Scrutiny Amid Shifting Markets

As regional markets navigate post-oil volatility and geopolitical shifts, a closer look reveals three penny stocks—from Turkish media to Saudi healthcare—that combine resilient balance sheets with high-risk, high-reward potential for the discerning investor.

Feb 2, 2026

World

Markets Retreat as AI Bubble Fears Resurface, Oil Prices Tumble

Global markets stumbled on Monday, with Asian shares and U.S. futures declining sharply. The sell-off was led by a significant pullback in South Korean tech stocks amid renewed concerns over an AI sector bubble, while oil prices dropped over $2 per barrel.

Feb 2, 2026

Business

IAS Bolsters Board with Ad-Tech Heavyweights, Signaling Streaming Ambitions

Integral Ad Science appoints Horizon Media's Bob Lord and Amazon's former video ad chief Krishan Bhatia to its board, a move analysts say sharpens its focus on the convergence of streaming, data, and advertising technology.

Feb 2, 2026

Business

Super Micro Computer Earnings Preview: Can the Server Giant Meet Lofty AI-Driven Expectations?

As Super Micro Computer (SMCI) prepares to release its quarterly results, the market watches to see if its AI server business can sustain explosive growth and justify its soaring valuation.

Feb 2, 2026

Business

Beyond the Ride: Why Uber's Strategic Pivot Makes Its Stock a Compelling Buy

Despite a recent stock dip following increased capital expenditures, Uber's aggressive investments in autonomous vehicles and AI services signal a transformative growth phase, underpinned by robust core financials.

Feb 2, 2026

Business

Perspective Therapeutics Surges on Promising Cancer Trial Data, But Valuation Gap Raises Questions

Shares of Perspective Therapeutics (CATX) have rallied sharply following encouraging interim results from its lead cancer therapy trial and a strategic business update. While the data fuels optimism, a deep dive into the numbers reveals a stark disconnect between its current market price and analyst targets, highlighting both opportunity and significant risk.

Feb 2, 2026

US

West Virginia Sees Major Immigration Enforcement Operation, Over 650 Arrested in Statewide Sweep

A coordinated two-week operation between ICE and multiple West Virginia law enforcement agencies has resulted in the arrest of more than 650 individuals for immigration violations, including some with criminal histories.

Feb 2, 2026

Business

Avery Dennison's Valuation in Focus as Smart Label Demand Offsets Market Volatility

Shares of materials and labeling giant Avery Dennison (NYSE: AVY) have shown resilience amid broader market swings, reigniting debate over its intrinsic value. With a significant gap between its current price and analyst targets, investors are weighing its growth in digital identification technologies against persistent sector headwinds.

Feb 2, 2026

Business

Exelixis Submits Zanzalintinib to FDA, Bolstering Oncology Pipeline with Key Colorectal Cancer Candidate

Exelixis has filed its next-generation therapy zanzalintinib with U.S. regulators for metastatic colorectal cancer, marking a significant step in its clinical development and potentially enhancing its competitive position in the targeted oncology space.

Feb 2, 2026